Physical Activity and Fibrosing Interstitial Lung Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Fibrotic interstitial lungs diseases (ILD) are a group of chronic and rare diseases characterized by an altered blood oxygenation in the lung, leading to dyspnea and physical limitation. Physical training is efficient to fight vicious circle of physical deconditioning observed in ILD. Eccentric cycling is an interesting modality of endurance training, allowing better exercise tolerance and adherence while developing cardiorespiratory function. Feasibility and efficacity of eccentric cycling were shown in chronic obstructive pulmonary disease but never in ILD. The primary aim of our work is to compare concentric and eccentric cycling training on physical capacities in ILD. Moreover, we will study the effects of training on the different steps of oxygen transport at exercise, from the lung to the muscles through the blood transport. Our second goal is then to characterize the physiological mechanisms underlying the benefits of exercising in ILD patients. Evaluations will be led during one year to study the long-term effects of training

Eligibility criteria

Qualifiers

Patient aged ≥ 18 years

Fibrosing PID with fibrosis score > 10% of lung volume on chest CT scan

Be able to attend physical reconditioning 3 times a week

Be affiliated to a health insurance scheme

Disqualifiers

Any contraindication to physical activity (hereafter, after Dany-Michel Marcadeta, Bruno Pavy et al. Recommendations of the French Society of Cardiology for stress tests 2018)

Be unable to perform exercise on an ergocycle or treadmill

Be unable to perform a stress test, particularly for people on long-term oxygen therapy rest oxygen therapy at home

IRS during an exacerbation

Trial design

Treatments tested in this trial

  • Training on eccentric ergocycle
  • Training on concentric ergocycle

Treatment groups

60 Participants
are divided into 2 treatment groups